Loading...
Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation
Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...
Na minha lista:
| Udgivet i: | Respir Med Case Rep |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8024693/ https://ncbi.nlm.nih.gov/pubmed/33854939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101393 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|